A Newspaper for the health conscious


Pinorc Life Science

Apollo Hospitals doctor performs 100 robotic ENT surgeries

1 1 1 1 1 1 1 1 1 1 Rating 5.00 (1 Vote)

NEW DELHI: Apollo hospitals-Delhi has announced that one of its doctors has completed 100 successful robotic ENT, head & neck surgeries in the last one year.

Dr Kalpana Nagpal, senior robotic ENT surgeon, conducted her first robotic assisted surgery in 2017 on an 18- year -old patient. Over the course of one year, the doctor became the first in the country to complete 100 such surgeries.

“Robotic surgeries provide advantages such as lesser blood loss, quicker recovery time, less scars and pain. “For robotic surgery, recovery time is on an average of 24 to 48 hours and there is a mean blood loss of only 1.1 grams. On the other hand, a laparoscopy will easily require at least 3 units of blood,” points out Dr Nagpal.

“As robotic procedures slowly become the medicine for the future, I am hopeful the cost of the machines, and the procedure, will also significantly reduce,” adds Dr Nagpal.

She said, “Movements by the robotic arms are miniature by 5 mm instruments, unlike gross hand movements of the surgeons making complex surgical procedures successful with high precision.”

In the procedure, surgical instruments are mounted on robotic arms which are operated by the surgeon.

Talking to DTMT, Dr Kalpana said, "The surgeons sit in a console which has a screen with a 3D view of the patient's body. His hand movements at the console are transmitted to the robotic arms placed over patient’s body.”

"During the entire procedure, the camera transmits live 3D images to the surgeon's console. It is like a laproscopic surgery," Dr Kalpana said

“Excellent cosmetics an added advantage due to which more and more patients are opting for robotic surgeries these days,” Dr Kalpana further explained.

Robotics can be used to treat snoring and obstructive sleep apnea, thyroid surgery, parathyroid surgery, neck dissections, tumours of oral cavity, oropharynx and larynx and recurrent nasopharyngeal cancer.

Leave your comments



  • No comments found


  • No comments found
GLS Pharma

Cubit Pharma